Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up

Ioannis Parodis,Thomas Stephens,Annica Dominicus,Daniel Eek,Christopher Sjöwall

DOI: https://doi.org/10.1093/rheumatology/keae120

2024-02-24

Rheumatology

Abstract:Abstract Objectives Beyond prevention of organ damage, treatment goals in systemic lupus erythematosus (SLE) include optimisation of health-related quality of life (HRQoL). The Lupus Low Disease Activity State (LLDAS) has received increasing attention as a goal whenever remission cannot be achieved. How SLE disease activity, organ damage, and LLDAS attainment relate to patient-reported outcomes (PROs) is not fully explored, which formed the scope of this investigation. Methods We included 327 patients with SLE from a tertiary referral centre. Longitudinal registrations of disease activity using SLEDAI-2K and physician global assessment (PhGA), organ damage using the SLICC/ACR damage index (SDI), pharmacotherapies, EQ-5D-3L data, as well as visual analogue scale (VAS) scores for fatigue, pain, and overall SLE-related health state over a median follow-up time of 8.5 years were analysed. Results In the overall population, as well as subgroups of patients with recent-onset SLE and those with clinically active, autoantibody-positive disease, LLDAS attainment, lower PhGA, and lower clinical SLEDAI-2K scores were associated with favourable HRQoL by EQ-5D-3L and VAS assessments, while increasing SDI scores were associated with poor PROs yet not fatigue in the overall population. PROs were further enhanced by being in LLDAS sustainedly. In fully adjusted models of the entire study population, LLDAS attainment and lower disease activity were associated with favourable PROs, irrespective of SDI. Conclusion In one of the longest to date observational studies, we demonstrated that low disease activity and being sustainedly in LLDAS were coupled with favourable HRQoL, pain, fatigue, and overall health experience, irrespective of organ damage.

rheumatology

What problem does this paper attempt to address?

This paper attempts to address how disease activity, low disease activity state (LLDAS), and organ damage affect health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE). The study mainly focuses on the following points:

1. **Disease Activity**: Investigated the impact of SLE disease activity on patients' HRQoL.
2. **LLDAS State**: Explored the relationship between LLDAS (low disease activity state) and patient-reported outcomes (PROs).
3. **Organ Damage**: Assessed the impact of organ damage on HRQoL.

Through a follow-up study lasting up to 11 years, the authors found:
- Lower disease activity and sustained LLDAS were associated with better HRQoL.
- Increased organ damage was associated with poorer HRQoL, except for fatigue symptoms.
- In fully adjusted models, LLDAS state and lower disease activity were associated with better PROs, regardless of the extent of organ damage.

This study provides important evidence for the treatment goals of SLE patients, indicating that controlling disease activity to the LLDAS level can significantly improve patients' quality of life.